Migraine and the risk of stroke, TIA, or death in the UK

Headache

Volumn 47, Issue 10, 2007, Pages 1374-1384

  Becker, Claudia ^a   Brobert, Gunnar P ^b   Almqvist, Per M ^b   Johansson, Saga ^c,d   Jick, Susan S ^e   Meier, Christoph R ^a,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ASTRAZENECA R AND D   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidemiology; General Practice Research Database; Migraine; Stroke; Triptan

Indexed keywords

TRIPTAN DERIVATIVE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORTALITY; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM;

ADULT; AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DEATH; FEMALE; GREAT BRITAIN; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK; STROKE;

EID: 36749018609     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00937.x     Document Type: Article

References (34)

1. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in The Young. Lancet. 1996 347 : 1503 1506.
2. Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol. 1995 52 : 129 134.
3. Merikangas KR, Fenton BT, Cheng SH, et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol. 1997 54 : 362 368.
4. Schwaag S, Nabavi DG, Frese A, et al. The association between migraine and juvenile stroke: A case-control study. Headache. 2003 43 : 90 95.
5. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: The Atherosclerosis Risk in Communities Study. Neurology. 2005 64 : 1573 1577.
6. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: A prospective study. Neurology. 2005 64 : 1020 1026.
7. Agostoni E, Fumagalli L, Santoro P, et al. Migraine and stroke. Neurol Sci. 2004 25 (Suppl. 3 S123 S125.
8. Gallai V, Sarchielli P, Floridi A, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 1995 15 : 384 390.
9. Zeller JA, Frahm K, Baron R, et al. Platelet-leukocyte interaction and platelet activation in migraine: A link to ischemic stroke? J Neurol Neurosurg Psychiatry. 2004 75 : 984 987.
10. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990 28 : 791 798.
11. Sanchez del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia. 1999 19 : 701 707.
12. Moschiano F, D'Amico D, Ciusani E, et al. Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: A link between migraine and ischaemic stroke? Neurol Sci. 2004 25 (Suppl. 3 S126 S128.
13. Villalon CM, Centurion D, Valdivia LF, et al. Migraine: Pathophysiology, pharmacology, treatment and future trends. Curr Vasc Pharmacol. 2003 1 : 71 84.
14. Goldberg LD. The cost of migraine and its treatment. Am J Manag Care. 2005 11 (2 Suppl S62 S67.
15. Lainez MJ, Lopez A, Pascual AM. Effects on productivity and quality of life of rizatriptan for acute migraine: A workplace study. Headache. 2005 45 : 883 890.
16. Dahlof C, Bouchard J, Cortelli P, et al. A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. Pharmacoeconomics. 1997 11 (Suppl. 1 24 34.
17. Mathew NT, Asgharnejad M, Peykamian M, et al. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group. Neurology. 1997 49 : 1485 1490.
18. Pascual J, Falk R, Docekal R, et al. Tolerability and efficacy of almotriptan in the long-term treatment of migraine. Eur Neurol. 2001 45 : 206 213.
19. Pfaffenrath V, Cunin G, Sjonell G, et al. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan. Headache. 1998 38 : 184 190.
20. Jick H. A database worth saving. Lancet. 1997 350 : 1045 1046.
21. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991 302 : 766 768.
22. Wood L, Martinez C. The general practice research database: Role in pharmacovigilance. Drug Saf. 2004 27 : 871 881.
23. Gibbs RG, Newson R, Lawrenson R, et al. Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: Experience of a national primary care database. Stroke. 2001 32 : 1085 1090.
24. Hall GC, Brown MM, Mo J, et al. Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004 62 : 563 568.
25. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004 24 (Suppl. 1 1 160.
26. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988 8 (Suppl. 7 1 96.
27. Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005 330 : 63.
28. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: Case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999 318 : 13 18.
29. Jousilahti P, Tuomilehto J, Rastenyte D, et al. Headache and the risk of stroke: A prospective observational cohort study among 35,056 Finnish men and women. Arch Intern Med. 2003 163 : 1058 1062.
30. Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002 22 : 633 658.
31. Waters WE, Campbell MJ, Elwood PC. Migraine, headache, and survival in women. BMJ (Clin Res Ed). 1983 287 : 1442 1443.
32. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006 296 : 283 291.
33. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: A prospective cohort study. Cephalalgia. 2007 27 : 368 371.
34. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001 32 : 280 299.